Aditxt, Inc.
ADTX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001726711
No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Aditxt, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 9 | 1 | −8 |
| Shares | 20.3K | 1 | −20.3K (−100.0%) |
| Value | $19.8K | $0 | −$19.8K (−100.0%) |
New holders (0)
Institutions that held Aditxt, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
None.
Sold out (8)
Institutions that held Aditxt, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Geode Capital Management, LLC | 11,721 | $11.5K |
| Morgan Stanley | 8,002 | $7.83K |
| Tower Research Capital LLC (TRC) | 547 | $535 |
| Danske Bank A/S | 3 | $3 |
| Group One Trading, L.P. | 2 | $2 |
| UBS Group AG | 1 | $1 |
| Darwin Advisors, LLC | 1 | $0 |
| Advisor Group Holdings, Inc. | 2 | $0 |